CONNECT COLLABORATE ACCELERATE
LIVE

Serial Number

79273882

Owner

BIOPHORUM OPERATIONS GROUP LIMITED

Attorney

Angela P. Doughty

Filing Date

May 16, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CONNECT COLLABORATE ACCELERATE Trademark

Serial Number: 79273882 • Registration: 6202711

CONNECT COLLABORATE ACCELERATE is a trademark filed by BIOPHORUM OPERATIONS GROUP LIMITED on May 16, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIOPHORUM OPERATIONS GROUP LIMITED (7 trademarks)

5 Westbrook Court, Sharrowvale Road

Entity Type: 99

Trademark Details

Filing Date

May 16, 2019

Registration Date

November 24, 2020

Published for Opposition

September 8, 2020

Goods & Services

Compiling data for research purpose in the field of medical science and medical consultancy; product development consultation; pharmaceutical research and development; consultancy on pharmaceutical product development, biopharmaceutical product development, biotechnology product development, medical device product development; technical research in the field of pharmaceutical studies; technical research in the field of biopharmaceuticals, biotechnology, medical devices and life science studies; technical consulting in the field of pharmaceutical studies; consultancy in the field of pharmaceutical research; testing, inspection, research, or development of pharmaceutical preparations; research on the subject of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; providing medical and scientific research information in the field of biopharmaceuticals, biotechnology, medical devices and life sciences; Developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Consultancy services in relation to developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Consultancy services in relation to quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Advisory in the field of quality control of manufactured goods; scientific research in the field of healthcare, medical technology, medical devices, life sciences, pharmaceutical, biopharmaceutical, and biotechnology; providing consultation in the field of science, healthcare, medical technology, medical devices, life sciences, pharmaceutical, biopharmaceutical, and biotechnology; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare, pharmaceuticals, biopharmaceuticals, and medical devices

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 24, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 27, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 27, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
ASSIGNED TO LIE
Aug 5, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 9, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 1, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 11, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 20, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 16, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 14, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2019 REPR